Mechanisms of Graft-versus-Host Disease Prevention by Post-transplantation Cyclophosphamide: An Evolving Understanding
Post-transplantation cyclophosphamide (PTCy) has been highly successful at preventing severe acute and chronic graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation (HCT). The clinical application of this approach was based on extensive studies in major histocompatibil...
Main Authors: | Natalia S. Nunes, Christopher G. Kanakry |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.02668/full |
Similar Items
-
Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-transplantation Cyclophosphamide and Anti-thymocyte Globulin as Graft-versus-Host Disease Prophylaxis
by: Maria Queralt Salas, et al.
Published: (2019-06-01) -
Elafin as a Predictive Biomarker of Acute Skin Graft-Versus-Host Disease After Haploidentical Stem Cell Transplantation Using Post-Transplant High-Dose Cyclophosphamide
by: Laura Solán, et al.
Published: (2021-02-01) -
Haploidentical stem cell transplant: Established treatment, expanding horizons
by: Mukul Aggarwal, et al.
Published: (2016-01-01) -
How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation
by: Benoît Vandenhove, et al.
Published: (2020-10-01) -
Interleukin-22 in graft-versus-host disease after allogeneic stem cell transplantation
by: BAPTISTE eLAMARTHEE, et al.
Published: (2016-04-01)